You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
BariSurg trial: Sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35–60 kg/m2 – a multi-centre randomized patient and observer blind non-inferiority trial
|
|---|---|
| Published in |
BMC Surgery, July 2015
|
| DOI | 10.1186/s12893-015-0072-7 |
| Pubmed ID | |
| Authors |
Lars Fischer, Anna-Laura Wekerle, Thomas Bruckner, Inga Wegener, Markus K. Diener, Moritz V. Frankenberg, Daniel Gärtner, Michael R. Schön, Matthias C. Raggi, Emre Tanay, Rainer Brydniak, Norbert Runkel, Corinna Attenberger, Min-Seop Son, Andreas Türler, Rudolf Weiner, Markus W. Büchler, Beat P. Müller-Stich |
| Abstract |
Roux-en-Ygastric bypass (RYGB) and sleeve gastrectomy (SG) rank among the most frequently applied bariatric procedures worldwide due to their positive risk/benefit correlation. A systematic review revealed a similar excess weight loss (EWL) 2 years postoperatively between SG and RYGB. However, there is a lack of randomized controlled multi-centre trials comparing SG and RYGB, not only concerning EWL, but also in terms of remission of obesity-related co-morbidities, gastroesophageal reflux disease (GERD) and quality of life (QoL) in the mid- and long-term. The BariSurg trial was designed as a multi-centre, randomized controlled patient and observer blind trial. The trial protocol was approved by the corresponding ethics committees of the centres. To demonstrate EWL non-inferiority of SG compared to RYGB, power calculation was performed according to a non-inferiority study design. Morbidity, mortality, remission of obesity-related co-morbidities, GERD course and QoL are major secondary endpoints. 248 patients between 18 and 70 years, with a body mass index (BMI) between 35-60 kg/m(2) and indication for bariatric surgery according to the most recent German S3-guidelines will be randomized. The primary and secondary endpoints will be assessed prior to surgery and afterwards at discharge and at the time points 3-6, 12, 24, 36, 48 and 60 months postoperatively. With its five year follow-up, the BariSurg-trial will provide further evidence based data concerning the impact of SG and RYGB on EWL, remission of obesity-related co-morbidities, the course of GERD and QoL. The trial protocol has been registered in the German Clinical Trials Register DRKS00004766 . |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| Unknown | 112 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 19% |
| Researcher | 13 | 12% |
| Student > Bachelor | 12 | 11% |
| Other | 8 | 7% |
| Student > Doctoral Student | 7 | 6% |
| Other | 19 | 17% |
| Unknown | 33 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 44% |
| Nursing and Health Professions | 8 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Computer Science | 2 | 2% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 14 | 12% |
| Unknown | 34 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2022.
All research outputs
#2,662,827
of 24,754,968 outputs
Outputs from BMC Surgery
#25
of 1,393 outputs
Outputs of similar age
#33,516
of 269,274 outputs
Outputs of similar age from BMC Surgery
#1
of 28 outputs
Altmetric has tracked 24,754,968 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,393 research outputs from this source. They receive a mean Attention Score of 2.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,274 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.